SonoStik, LLC

SonoStik, LLC develops and manufactures advanced medical devices to improve venous access, focusing on efficiency and ease of use for clinicians in high-pressure medical environments. Founded in 2013 in Washington, US, SonoStik, LLC creates innovative medical devices, notably the SonoStik IV Guidewire Introducer, which enhances the IV placement process. The company has engaged in 2 investment deals, with the most recent being a funding round in June 2021. The company is led by CEO Dick Fogel and Gary Wakeford.

The specific amount raised in the latest Series A round was USD 1. 00 mn, which is also the total amount raised to date. SonoStik, LLC specializes in the design and manufacture of innovative medical devices aimed at enhancing venous access for clinicians. Their core product, the SonoStik IV Guidewire Introducer, facilitates the peripheral intravenous (IV) placement process, allowing healthcare professionals to manage the guidewire, needle, and catheter with a single hand.

This device is particularly beneficial in emergency departments, intensive care units, and operating rooms, where quick and efficient vascular access is critical. Optimized for use with portable ultrasound technology, SonoStik primarily serves hospitals and healthcare facilities in the US, while also expanding to international markets. Information regarding the specific revenue of SonoStik is not disclosed. The company engages in direct business-to-business (B2B) transactions with hospitals and healthcare providers, positioning its flagship product, the SonoStik IV Guidewire Introducer, as a critical tool in the vascular access process.

Transactions are typically structured around the sale of individual units or bulk orders, supporting healthcare facilities in equipping their staff with essential tools for patient care. In June 2021, SonoStik, LLC raised USD 1. 00 mn in a Series A round led by DisruptAD. The funding will be utilized to launch its product line in the UAE and other new markets.

The company aims to expand its reach and improve healthcare outcomes through innovative product offerings tailored to meet the needs of various healthcare facilities.